Abstract | UNLABELLED: METHODS: Six radiopharmaceuticals were studied: three for PET [ 18F-fluorodeoxyglucose (FDG), L-18F-alpha-methyltyrosine (FMT) and 11C-methionine (C-Met)] and three for scintimammography [99mTc-tetrofosmin (TF), 99mTc-sestamibi (MIBI) and 201Tl-chloride (Tl)]. Biodistributions of six different tracers in mice implanted with MCF-7 breast cancer cells were studied 1 and 3 hr after injection. RESULTS:
Tumor uptake 1 hr after injection was FMT = C-Met > FDG = TF > MIBI = Tl. Thallium-201-chloride showed the highest tumor-to-blood ratio (T/B) among all radiopharmaceuticals because of its fast clearance from circulation. The T/B of the six radionuclides used in this study ranged from 1.26 for C-Met to 12.83 for Tl. Tumor-to-muscle ratio (T/M) revealed FMT = C-Met > FDG > MIBI > TF = Tl. The T/M ranged from 0.20 for TF to 2.29 for FMT. Tumor-to-lung ratio (T/L) varied from 0.45 for TF to 2.41 for FMT. FMT revealed the highest T/L of all six radiopharmaceuticals. CONCLUSION: Among radiopharmaceuticals for PET, FMT seemed to be suitable in detecting MCF-7 tumor; whereas for scintimammography, MIBI, TF and Tl appeared to have almost the same detectability of MCF-7 tumor. The results of this study strongly suggest that FMT may have a potential in breast cancer imaging.
|
Authors | S Amano, T Inoue, K Tomiyoshi, T Ando, K Endo |
Journal | Journal of nuclear medicine : official publication, Society of Nuclear Medicine
(J Nucl Med)
Vol. 39
Issue 8
Pg. 1424-7
(Aug 1998)
ISSN: 0161-5505 [Print] United States |
PMID | 9708521
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Fluorine Radioisotopes
- Radiopharmaceuticals
- alpha-Methyltyrosine
|
Topics |
- Animals
- Breast Neoplasms
(diagnostic imaging, metabolism)
- Female
- Fluorine Radioisotopes
(pharmacokinetics)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Neoplasm Transplantation
- Radiopharmaceuticals
(pharmacokinetics)
- Tissue Distribution
- Tomography, Emission-Computed
- Tomography, Emission-Computed, Single-Photon
- alpha-Methyltyrosine
(pharmacokinetics)
|